APA (7th ed.) Citation

Inoue, T., Kunimasa, K., Tamiya, M., Kawamura, T., Minami, T., & Nishino, K. (2024). Exceptionally long‐lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD‐L1: A case report. Thoracic Cancer, 15(11), 929. https://doi.org/10.1111/1759-7714.15254

Chicago Style (17th ed.) Citation

Inoue, Takako, Kei Kunimasa, Motohiro Tamiya, Takahisa Kawamura, Toshiyuki Minami, and Kazumi Nishino. "Exceptionally Long‐lasting Response to Dabrafenib Plus Trametinib Treatment in a Patient with Lung Adenocarcinoma Harboring the BRAF V600E Mutation with High Expression of PD‐L1: A Case Report." Thoracic Cancer 15, no. 11 (2024): 929. https://doi.org/10.1111/1759-7714.15254.

MLA (9th ed.) Citation

Inoue, Takako, et al. "Exceptionally Long‐lasting Response to Dabrafenib Plus Trametinib Treatment in a Patient with Lung Adenocarcinoma Harboring the BRAF V600E Mutation with High Expression of PD‐L1: A Case Report." Thoracic Cancer, vol. 15, no. 11, 2024, p. 929, https://doi.org/10.1111/1759-7714.15254.